Amyotrophic Lateral Sclerosis News and Research

RSS

New environmental risk score assesses a person's risk for developing ALS using blood sample

Over the last decade, research at Michigan Medicine has shown how exposure to toxins in the environment, such as pesticides and carcinogenic PCBs, affect the risk of developing and dying from amyotrophic lateral sclerosis.

30 Oct 2023

Brain-computer interface helps ALS patient control devices, navigate communication board

It's the day after the Baltimore Orioles clinched the American League East Championship with their 100th win of the season, and lifelong fan Tim Evans is showing his pride on his sleeve.

25 Oct 2023

Coffee consumption reduces risk of migraines, but not other neurological diseases

Researchers use Mendelian randomization to establish a causal link between coffee consumption and reduction in migraine risk.

20 Oct 2023

European Union needs action plan to provide better diagnoses, treatment for rare diseases

At its conference in Bilbao, the European Economic and Social Committee (EESC) urged the European Union to launch a European action plan stepping up cooperation between national health systems.

14 Oct 2023

New drug molecule restores lost nerve-muscle connections, enhances strength

A small molecule previously shown to enhance strength in injured or old laboratory mice does so by restoring lost connections between nerves and muscle fibers, Stanford Medicine researchers have found.

11 Oct 2023

How do micronutrients influence neurological disorders?

The knowledge about micronutrients with regard to selected neurological diseases.

27 Sep 2023

Scientists decode the marker protein that can be used to ‘‘see’’ neuroinflammation

Inflammation is the sign that our body is defending itself against an aggression. But when this response escalates, for example in the brain, it can lead to serious neurological or psychiatric diseases.

25 Sep 2023

Researchers find a promising drug candidate for the treatment of ALS

A research group at the University of Helsinki and its partners have found a promising drug candidate for the treatment of amyotrophic lateral sclerosis (ALS).

22 Sep 2023

Ongoing gene therapy trials have driven increased use of ALS genetic testing, finds study

Researchers at The Ohio State University Wexner Medical Center and College of Medicine led the creation of evidence-based consensus guidelines for genetic testing and counseling for patients with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.

19 Sep 2023

Is maple syrup the ultimate natural sweetener? Researchers say it's more than just tasty!

Scientists explore the myriad benefits of maple syrup, revealing its nutritional, pharmacological, and sensory advantages over traditional sweeteners. From antioxidant and anti-inflammatory properties to controlling blood sugar and even potential anticancer effects, maple syrup is more than just a tasty topping.

14 Sep 2023

People who require specialized neurologic care most often travel long distances, study finds

Nearly one in five people on Medicare travel 50 or more miles one way to see a neurologist, a doctor who diagnoses and treats diseases of the brain and nervous system, according to research published in the September 13, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Sep 2023

Unhealthy pathobiome in the brain could cause some forms of Alzheimer's and related dementias

The human microbiome includes the genetic material of more than 100 trillion tiny microorganisms – fungi, yeast, bacteria, and even viruses, most of which hang out in our gastrointestinal tract to serve as guardians of our health.

13 Sep 2023

Scientists develop new method to detect key fat-filled particles in the brain

Scientists have created a method to detect key fat-filled particles known as lipoproteins in the central nervous system, opening a new view into the workings of the brain.

12 Sep 2023

Ohio State University Wexner Medical Center administers first targeted gene therapy for ALS

The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.

8 Sep 2023

Amyotrophic Lateral Sclerosis News and Research

New environmental risk score assesses a person's risk for developing ALS using blood sample

Brain-computer interface helps ALS patient control devices, navigate communication board

Coffee consumption reduces risk of migraines, but not other neurological diseases

European Union needs action plan to provide better diagnoses, treatment for rare diseases

New drug molecule restores lost nerve-muscle connections, enhances strength

How do micronutrients influence neurological disorders?

Scientists decode the marker protein that can be used to ‘‘see’’ neuroinflammation

Researchers find a promising drug candidate for the treatment of ALS

Ongoing gene therapy trials have driven increased use of ALS genetic testing, finds study

Is maple syrup the ultimate natural sweetener? Researchers say it's more than just tasty!

People who require specialized neurologic care most often travel long distances, study finds

Unhealthy pathobiome in the brain could cause some forms of Alzheimer's and related dementias

Scientists develop new method to detect key fat-filled particles in the brain

Ohio State University Wexner Medical Center administers first targeted gene therapy for ALS

Speech Accessibility Project needs more participants with Parkinson's

Engineered adeno-associated virus vector yields high transduction of the brain vasculature

Zebrafish model could help unlock Parkinson's disease mechanisms

A new Medicare proposal would cover training for family caregivers

Machine learning in neurodegenerative disease research: a growing trend

Study finds α5 integrin as a potential therapeutic target in amyotrophic lateral sclerosis

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News